OX2 Therapeutics
About:
OX2 Therapeutics is a healthcare therapeutics company that focuses on treating brain tumors.
Website: https://ox2therapeutics.com
Description:
OX2 Therapeutics is a healthcare therapeutics company that focuses on treating brain tumors. Its novel CD200 Checkpoint peptide inhibitor activates the immune system through a CD200 activation receptor, enabling healthcare institutes to apply receptor antibodies that permit the immune system army to pass through blood vessel walls and kill cancer activities.
Total Funding Amount:
$649000
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Minneapolis, Minnesota, United States
Founded Date:
2016-06-01
Founders:
Christopher Moertel, Sumant Dhawan
Number of Employees:
1-10
Last Funding Date:
2020-09-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai